HomeTagsImmuno-oncology

immuno-oncology

Biotechnology

Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology

PR Newswire - June 1, 2022

Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and GO Therapeutics, Inc. (Co-Founder and CEO: Constantine Theodoropulos, "GO") announced that Xyphos Biosciences,...

Healthcare

CytoReason Collaborates with Merck KGaA, Darmstadt, Germany, on Cancer Immunotherapy Drug

PR Newswire - October 20, 2021

CytoReason, an Israeli company developing computational disease models for more efficient drug discovery and development, today announced a collaboration with German multinational science and...